Table 3.
Odds Ratio of Cognitive Impairment (95% CI) | ||||||
---|---|---|---|---|---|---|
Unadjusted Model | p Value | Base Model* | p Value | MV Model† | p Value | |
eGFRCysC ‡ quartiles, mL/min/1.73 m2 | ||||||
Q4 (76.1–109.4) | 1.08 (0.82–1.41) | .580 | 1.13 (0.85–1.49) | .403 | 1.18 (0.88–1.58) | .276 |
Q2–Q3 (55.6–76.0) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | |||
Q1 (21.8–55.5) | 1.42 (1.09, 1.85) | .010 | 1.37 (1.05–1.80) | .022 | 1.26 (0.94–1.67) | .117 |
eGFRCr+CysC § quartiles, mL/min/1.73 m2 | ||||||
Q4 (81.2–116.4) | 1.24 (0.95–1.62) | .121 | 1.25 (0.94–1.66) | .124 | 1.35 (1.01–1.82) | .046 |
Q2–Q3 (61.9–81.1) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | |||
Q1 (23.5–61.8) | 1.45 (1.11–1.90) | .007 | 1.36 (1.03–1.79) | .029 | 1.29 (0.97–1.71) | .080 |
eGFRCr || quartiles, mL/min/1.73 m2 | ||||||
Q4 (86.1–115.1) | 1.15 (0.88–1.50) | .317 | 1.27 (0.95–1.69) | .106 | 1.32 (0.98–1.77) | .068 |
Q2–Q3 (66.5–86.0) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | |||
Q1 (21.6–66.4) | 1.13 (0.86–1.48) | .368 | 1.13 (0.86–1.49) | .379 | 1.09 (0.82–1.45) | .535 |
Notes: eGFR = estimated glomerular filtration rate.
*Adjusted for age and race.
†Adjusted for multiple covariates, including age, race, education, self-reported health status, Geriatric Depression Scale, Instrumental Activities of Daily Living, smoking, alcohol intake, body mass index, history of coronary vascular disease, history of diabetes, history of hypertension, and history of stroke.
‡Calculated by the CKD-EPI cystatin C equation (27).
§Calculated by the CKD-EPI creatinine–cystatin C equation (27).
||Calculated by the CKD-EPI creatinine equation (27).